Labshake search
Citations for R&D Systems :
301 - 350 of 3443 citations for Erythromycin 90 95% Erythromycin A N N Dimethyl 13C2 ~90% 100 Ug Ml In Mtbe since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2022Quote: ... 100 units/mL penicillin and 0.1 mg/mL streptomycin and also with 10μM Y-27632 (ROCK inhibitor; R&D Systems) and 10μM SB 431542 (TGF-βRI inhibitor ...
-
bioRxiv - Bioengineering 2023Quote: ... Organoid basal growth media was supplemented with epidermal growth factor (EGF) (100 ng/mL, 10 ng/mL, 1 ng/mL R&D Systems Cat#236-EG-01M) or Epiregulin (EREG ...
-
bioRxiv - Neuroscience 2021Quote: ... where the medium was supplemented with recombinant Netrin (100 ng/ml, R&D Systems).
-
bioRxiv - Biochemistry 2022Quote: ... and supplemented with 100 ng/mL activin A (R&D Systems, Minneapolis, MN, USA) and 1% B27 minus insulin (Thermo Fisher Scientific) ...
-
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s diseasebioRxiv - Neuroscience 2020Quote: ... 100 ng/ml recombinant human sonic hedgehog (SHH) (R&D systems, 464-SH-025CF), 2 μM purmorphamine (Reprocell ...
-
bioRxiv - Neuroscience 2022Quote: ... NLGN1 (Sino Biological, Cat. 11617-H08H-100, R&D Systems, Cat. AF4340, 50ng/mL), TSLP (Sino Biological ...
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Developmental Biology 2019Quote: ... After 2 days EBs were treated with 100 ng/ml Noggin (R&D Systems) and 10 mM SB431542 (Tocris ...
-
bioRxiv - Cell Biology 2019Quote: ... in the presence or not of IL-36RA (R&D Systems, 100 ng/ml) or Sunitinib (Pfizer S.r.l. ...
-
bioRxiv - Microbiology 2020Quote: ... followed by 4 days with 200ng/ml Noggin (R&D Systems, 6057-NG-100), 500ng/ml FGF4 (Peprotech ...
-
bioRxiv - Biophysics 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript ...
-
bioRxiv - Neuroscience 2022Quote: ... and 100 ng/mL OX-2 membrane glycoprotein (CD200) (R&D systems, cat.no. 27712CD050) growth factors in addition to the previously described growth factors.
-
bioRxiv - Immunology 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript).
-
bioRxiv - Biophysics 2023Quote: ... and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ, R&D Systems) (Farnsworth et al. ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... penicillin-streptomycin) supplemented with 100 ng/mL EGF (R&D Systems, cat # 236-EG) and 100 ng/mL of BMP2 (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... and mouse epidermal growth factor (100 ng/ml) (R&D Systems, #2028-EG-200). Cells were plated in a six-well dish at a density of about 2 retinas per 10cm2 well ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Cell Biology 2024Quote: ... cells were stimulated with 100 ng/mL recombinant WNT3A (R&D Systems, 5036-WN) or WNT5A (R&D Systems ...
-
bioRxiv - Genomics 2024Quote: ... cells were also treated with or without TNFα (R&D systems, 100 ng/ml) at 48 h after transfection and harvested at 72 h after transfection (24 h after TNFα treatment).
-
bioRxiv - Developmental Biology 2023Quote: ... heating at 95°C for 5 min in antigen retrieval solution (CTS045, R&D Systems, Minneapolis, MN). After blocking non-specific binding in 2% non-fat milk in 0.1 M PBS containing 0.1% Triton X-100 (PBS/MT ...
-
bioRxiv - Microbiology 2023Quote: ... 100 µg/ml streptomycin and either 5 ng/ml granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems, Abingdon, UK) to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Microbiology 2023Quote: ... ligand-loaded CD1d (0.25 ug per well) was bound onto Streptavidin-coated plates (R&D Systems #CP003). Plates were washed with PBS three times and then added 24.7 NKT cells (4 x 104∼105 per well ...
-
bioRxiv - Synthetic Biology 2021Quote: ... in a 1:1 ratio with 100 U mL-1 of IL-7 and 10U mL-1 IL-15 (R&D Systems) in tissue culture flasks ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with recombinant human IL-4 (50 ng/mL) and recombinant human GM-CSF (100 ng/mL) (R&D Systems, Minneapolis, MN) with one additional supplement of fresh media and cytokines at day 3 of culture as previously described 12 ...
-
bioRxiv - Developmental Biology 2019Quote: ... and 100 ng/ml CHO-derived mouse R-spondin 1 or 5 ng/ml CHO-derived mouse R-spondin 2 (R&D System). The final concentration of Rspondins in the culture medium was initially tested in pilot experiments in order to add comparable amounts of bioactive ligands (bioactivity measured by TOPflash assays and organoid growth curves ...
-
bioRxiv - Immunology 2020Quote: ... and then re-suspended in 30 μL of media containing 10,000 units/mL of recombinant IFN-α2a or 100 units/mL of recombinant IFN-γ (R&D Systems). Antibodies against SiglecF ...
-
bioRxiv - Neuroscience 2023Quote: ... or bFGF (10 ng/mL) and diazepam (100 μM) (045-18901, Wako) or BMP4 (50 ng/mL) (5020-BP, R&D Systems) (quiescence medium ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Neuroscience 2021Quote: ... the supplements in the medium were replaced with FGF8 (100 ng/ml; R&D Systems). From day 11 ...
-
bioRxiv - Genomics 2022Quote: ... 15140122) supplemented with final 100 ng/ml Activin-A (R&D Systems, 338-AC-01M) and 1,4 µg/ml CHIR99021 (Stemgent ...
-
bioRxiv - Bioengineering 2023Quote: ... iASCs were prepared by pretreating ASCs with interferon γ (100 ng/ml; R&D Systems) in ASC culture medium for 24 hours ...
-
bioRxiv - Genomics 2023Quote: ... (Thermo Fisher Scientific)] medium supplemented with recombinant human/mouse/rat activin A (100 ng/mL; R&D Systems) for 18 hours ...
-
bioRxiv - Cell Biology 2023Quote: ... alone or sequentially with 100 μL/mL polylysine and 400 ng/mL netrin-1 (R&D systems, catalog number 6419-N1-025/CF), and cultured in Neurobasal Medium (Thermo Fisher Scientific ...
-
bioRxiv - Neuroscience 2020Quote: ... Glass coverslips were coated with alternating stripes (IgG or Sema7a 100 μg/ml, R&D Systems), which were then covered by laminin (20 μg/ml) ...
-
bioRxiv - Cell Biology 2020Quote: ... 5μM Y-27632 and 100 ng/ml recombinant mouse Noggin (R&D Systems, 1967-NG-025)) ...
-
bioRxiv - Genetics 2023Quote: ... in presence or absence of IFN γ (R&D Systems, 485-MI-100, 10 ng/ml). On day 2 of reprogramming ...
-
bioRxiv - Genetics 2023Quote: ... in presence or absence of IFN γ (R&D Systems, 485-MI-100, 10 ng/ml) for the first 5 days ...
-
bioRxiv - Immunology 2023Quote: ... CTL medium containing 100 IU/ml human IL-2 (R&D Systems, 202-IL-010/CF) was added to the plates and the expansion of T cells continued ...
-
bioRxiv - Biochemistry 2023Quote: ... and 10 ng/mL recombinant mouse interferon-γ (IFN-γ) (R&D Systems, 485-MI-100) were added to the media and maintained with subsequent media change.
-
bioRxiv - Cell Biology 2023Quote: ... starved overnight and exposed to 1.5 ng/ml of TFGβ (#100-B-001, R&D Systems) for 6 and 24 hours ...
-
bioRxiv - Cell Biology 2024Quote: ... Purified human recombinant HGF (100-250 ng/ml, as indicated) was obtained from R&D Systems. Protein-A Gold 10 nm was from Utrecht University ...
-
bioRxiv - Immunology 2024Quote: ... #CCL-131) were plated in each well of 96-well plates and preactivated with 100 ng/mL mouse IFN-γ (R&D Systems, #485-MI-100) for 18-24 hours ...
-
bioRxiv - Cancer Biology 2020Quote: ... pH6.0 at 95°C followed by 1h blocking and incubation with pre-optimized primary anti-UCHL1 (MAB6007, R&D Systems) or anti-p53 (Dako ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 100 µl) in N2-S medium supplemented with 20 ng/ml EGF and 20 ng/ml FGF2 (both from R&D Systems, Minneapolis, Minnesota, USA) into the upper chamber ...
-
bioRxiv - Neuroscience 2021Quote: ... The neural medium was supplemented with 10 ng/mL epidermal growth factor (PreproTech, AF-100-15) and 10 ng/mL basic fibroblast growth factor (R&D Systems, 234-FSE-025) and changed daily until day 12 ...
-
bioRxiv - Molecular Biology 2022Quote: ... The neural medium was supplemented with 10 ng/mL epidermal growth factor (PreproTech AF-100-15) and 10 ng/mL basic fibroblast growth factor (R&D Systems 234-FSE-025). From day 6 to day 10 the medium was changed everyday until the appearance of rosettes ...
-
bioRxiv - Cell Biology 2023Quote: ... osteoclast differentiation was initiated using αMEM complete media supplemented with 30 ng/mL M-CSF and 100 ng/mL RANKL (R&D Systems, 462-TEC/CF)(57) ...
-
bioRxiv - Cancer Biology 2019Quote: ... medium was supplemented with a growth factor cocktail for recovery (100 ng/ml EGF (R&D Systems), 100 ng/ml FGF1 (R&D Systems) ...